Literature DB >> 3258423

Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype.

S Mendlovic1, S Brocke, Y Shoenfeld, M Ben-Bassat, A Meshorer, R Bakimer, E Mozes.   

Abstract

Systemic lupus erythematosus (SLE) is considered to be the quintessential autoimmune disease. It has not been possible to induce SLE in animal models by DNA immunization or by challenge with anti-DNA antibodies. We herewith report a murine model of SLE-like disease induced by immunization of C3H.SW female mice with a common human monoclonal anti-DNA idiotype (16/6 idiotype). Following a booster injection with the 16/6 idiotype, high levels of murine anti-16/6 and anti-anti-16/6 antibodies (associated with anti-DNA activity) were detected in the sera of the immunized mice. Elevated titers of autoantibodies reacting with DNA, poly(I), poly(dT), ribonucleoprotein, autoantigens [Sm, SS-A (Ro), and SS-B (La)], and cardiolipin were noted. The serological findings were associated with increased erythrocyte sedimentation rate, leukopenia, proteinuria, immune complex deposition in the glomerular mesangium, and sclerosis of the glomeruli. The immune complexes in the kidneys were shown to contain the 16/6 idiotype. This experimental SLE-like model may be used to elucidate the mechanisms underlying SLE.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258423      PMCID: PMC279970          DOI: 10.1073/pnas.85.7.2260

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Profiles of antinuclear antibodies in systemic rheumatic diseases.

Authors:  D D Notman; N Kurata; E M Tan
Journal:  Ann Intern Med       Date:  1975-10       Impact factor: 25.391

2.  Studies on the chemical basis of the antigenicity of proteins. 5. Synthesis, characterization and immunogenicity of some multichain and linear polypeptides containing tyrosine.

Authors:  M SELA; S FUCHS; R ARNON
Journal:  Biochem J       Date:  1962-10       Impact factor: 3.857

Review 3.  Origins of anti-DNA autoantibodies.

Authors:  R S Schwartz; B D Stollar
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

4.  Molecular properties of the Ro/SSA antigen and enzyme-linked immunosorbent assay for quantitation of antibody.

Authors:  H Yamagata; J B Harley; M Reichlin
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

5.  Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas.

Authors:  Y Shoenfeld; J Rauch; H Massicotte; S K Datta; J André-Schwartz; B D Stollar; R S Schwartz
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

6.  Anti-DNA antibody idiotypes in systemic lupus erythematosus.

Authors:  D A Isenberg; Y Shoenfeld; M P Madaio; J Rauch; M Reichlin; B D Stollar; R S Schwartz
Journal:  Lancet       Date:  1984-08-25       Impact factor: 79.321

7.  Responsiveness of autoimmune and normal mice to nucleic acid antigens.

Authors:  M P Madaio; S Hodder; R S Schwartz; B D Stollar
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

8.  Detection of cross reactive anti-DNA antibody idiotypes on tissue-bound immunoglobulins from skin biopsies of lupus patients.

Authors:  D Isenberg; C Dudeney; F Wojnaruska; B S Bhogal; J Rauch; A Schattner; Y Naparstek; D Duggan
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

9.  Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA. Possible role of anti-idiotypic antibodies.

Authors:  B H Hahn; F M Ebling
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

10.  Idiotypic cross-reactions of monoclonal human lupus autoantibodies.

Authors:  Y Shoenfeld; D A Isenberg; J Rauch; M P Madaio; B D Stollar; R S Schwartz
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  68 in total

1.  Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody.

Authors:  M Dayan; R Segal; Z Sthoeger; A Waisman; N Brosh; O Elkayam; E Eilat; M Fridkin; E Mozes
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

2.  Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibody.

Authors:  E Eilat; H Zinger; A Nyska; E Mozes
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

3.  Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus.

Authors:  Defu Zeng; Yinping Liu; Stephane Sidobre; Mitchell Kronenberg; Samuel Strober
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 4.  The biochemistry and genetics of DNA and anti-DNA antibodies.

Authors:  B D Stollar
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

5.  Chimaeric monoclonal antibodies encoded by the human VH26 gene from naïve transgenic mice display a wide range of antigen-binding specificities.

Authors:  I J Harmer; R A Mageed; A Kaminski; P Charles; M Brüggemann; C G Mackworth-Young
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

6.  Polyclonal B-cell expansion in the cerebrospinal fluid of patients with pseudotumor cerebri.

Authors:  Reng-Rong Da; Grace Kao; Wen-Zhong Guo; Michael Olek; Sudhir Gupta; Yiping Zhang; Stanley Van Den Noort; Yufen Qin
Journal:  J Clin Immunol       Date:  2004-11       Impact factor: 8.317

7.  Autoantibodies to brain and polynucleotides in patients with schizophrenia: a puzzle.

Authors:  H A Teplizki; B Sela; Y Shoenfeld
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 8.  Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology.

Authors:  J B Harley; R H Scofield
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

9.  Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.

Authors:  M Satoh; A Kumar; Y S Kanwar; W H Reeves
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

10.  Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome.

Authors:  Z M Sthoeger; B Tartakovsky; Z Bentwich; E Mozes
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.